Cambridge Investment Research Advisors
COLL icon

Cambridge Investment Research Advisors’s Collegium Pharmaceutical COLL Stock Holding History

Cambridge Investment Research Advisors’s Portfolio COLL Stock Details COLL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q3 		– Sell
-11,549
Closed -$248K – 3163
2023
Q2 		$248K Sell
11,549
-303,957
-96% -$6.9M ﹤0.01% 2697
2023
Q1 		$7.57M Sell
315,506
-1,119
-0.4% -$29.7K 0.04% 453
2022
Q4 		$7.35M Buy
316,625
+247,697
+359% +$4.99M 0.04% 447
2022
Q3 		$1.1M Buy
+68,928
New +$1.22M 0.01% 1406

Other funds holding COLL

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCMNY
Rubric Capital Management (New York) New York $9.44B AUM 68.42% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return
Pacer Advisors
Pacer Advisors Malvern, Pennsylvania $35.6B AUM 18.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return

Cambridge Investment Research Advisors's COLL Position: Q3 2023 in Review

Cambridge Investment Research Advisors sold out of Collegium Pharmaceutical (COLL) in Q3 2023, closing a stake of 11,549 shares — an estimated $248K sold.

Cambridge Investment Research Advisors first reported a position in COLL in Q3 2022 and held it in 4 quarters. The position peaked at $7.57M in Q1 2023. 174 funds tracked by Wall St. Rank hold COLL as of Q3 2023.

  • Cambridge Investment Research Advisors reported no remaining Collegium Pharmaceutical position as of Q3 2023 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 11,549 Collegium Pharmaceutical shares in Q3 2023, an estimated $248K.
  • Cambridge Investment Research Advisors first reported a position in Collegium Pharmaceutical in Q3 2022 and held it in 4 quarters.
  • Cambridge Investment Research Advisors's Collegium Pharmaceutical position peaked at $7.57M in Q1 2023.
  • 174 funds tracked by Wall St. Rank held Collegium Pharmaceutical as of Q3 2023.

Based on Cambridge Investment Research Advisors's 13F filing for Q3 2023, filed 24 Oct 2023.